| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 18 |
| 1 | DULOXETINE | 8 |
| 2 | DULOXETINE HYDROCHLORIDE | 8 |
| 3 | ENALAPRIL | 8 |
| 4 | MELATONIN | 8 |
| 5 | METOPROLOL | 8 |
| 6 | METOPROLOL TARTRATE | 8 |
| 7 | METOPROLOL TARTRATE INJECTION | 8 |
| 8 | OMEPRAZOLE | 8 |
| 9 | OMEPRAZOLE MAGNESIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFENOQUINE | 1 | 0.0152 |
| 1 | OMEGA-3-ACID ETHYL ESTERS | 2 | 0.0010 |
| 2 | LEMBOREXANT | 1 | 0.0003 |
| 3 | SUMATRIPTAN SUCCINATE | 8 | 0.0003 |
| 4 | SUMATRIPTAN | 8 | 0.0002 |
| 5 | PEMBROLIZUMAB | 18 | 0.0002 |
| 6 | PIROXICAM | 1 | 0.0002 |
| 7 | BETAMETHASONE DIPROPIONATE | 1 | 0.0001 |
| 8 | EDOXABAN TOSYLATE | 1 | 0.0001 |
| 9 | MELATONIN | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] | 8 | 0.0003 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 18 | 0.0002 |
| 2 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 3 | Glinide [EPC] | 1 | 0.0001 |
| 4 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Vitamin C [EPC] | 9 | 0.0000 |
| 7 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Aromatase Inhibitor [EPC] | 2 | 0.0000 |